# Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

> **NCT05656469** · NA · RECRUITING · sponsor: **Maastricht University Medical Center** · enrollment: 2500 (estimated)

## Conditions studied

- Mood Disorders
- Anxiety Disorders
- Psychotic Disorders

## Interventions

- **OTHER:** Personalised medication advice based on pharmacogenetic testing

## Key facts

- **NCT ID:** NCT05656469
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-23
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656469, "Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05656469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*